arrow
J

Juefeng Wan

fudan university
H指数:20
被引数:2,023

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant short-course radiotherapy combined with chemotherapy and a PD-1 inhibitor for resected mucosal melanoma: study protocol for a single-arm, prospective, phase II trial

辅助短程放疗联合化疗和PD-1抑制剂治疗切除后黏膜黑色素瘤:单臂、前瞻性、II期试验研究方案

2026-04-160
PRE
Comprehensive dissection of rectal cancer organoids in responses to chemoradiation

直肠癌细胞类器官对化学放疗反应的全面剖析

2025-10-030
OAAI
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial

根据UGT1A1状态指导的卡培他滨联合伊立替康新辅助放化疗在局部晚期直肠癌患者中的应用:CinClare试验5年更新

2025-09-030
OAAI
Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis

新辅助治疗后完全缓解的直肠癌患者回顾性队列的长期结果: 倾向评分加权分析

2023-09-082
OAAI
Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

患者来源的肿瘤类器官可预测局部晚期直肠癌患者对基于伊立替康的新辅助放化疗的反应

2022-10-0519
PRE
A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing study

围手术期化学免疫疗法与围手术期化学免疫疗法加术前放化疗治疗局部晚期胃 (G) 或胃食管交界处 (GEJ) 腺癌的随机II期试验的研究方案: NeoRacing研究

2022-06-281
OAAI
Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH)

短程放疗联合CAPOX和Toripalimab用于局部晚期直肠癌的全部新辅助治疗: 一项随机,前瞻性,多中心,双臂,II期试验 (TORCH)

2022-03-1530
OAAI